Share

Networks

Clinical Studies (2)

  • SeVIHPrEP : Study aims to evaluate clinical benefits and drawbacks of antiretroviral drugs as pre-exposure prophylaxis to prevent HIV infection under real-life conditions among persons who pursue high-risk sexual practices
  • BLOC : Study aims to investigate the efficacy, pharmacodynamics and safety of BC 007 in improving long COVID symptoms by neutralising functional autoantibodies targeting G-protein

Study Data

  • Adults
  • General population
  • Elderly
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Non-hospital health centre
  • STD/STI clinic
  • SARS-CoV-2
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Mycoplasma genitalium
  • Hepatitis
  • HIV
  • Treponema pallidum
  • Post-COVID-19
  • Sexually transmitted infection
  • Anal-rectal swab
  • Oral swab
  • Urethral exudate
  • Pharmacological intervention
  • PrEP-HIV
  • BC 007

Other information

If you would like to contact the site, please email: ccb@ateneo.univr.it

The data is updated up to